Theravie Pharma, Inc.
PrivateLast Round
Seed
Sep 29, 2026
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Theravie Pharma, Inc. is a biotechnology company that develops innovative treatments for acne and other inflammatory skin diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Theravie Pharma, Inc. Comparables
Compare Theravie Pharma, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MatriSys Bioscience | 85% | |
| SFA Therapeutics | 77% | |
| Dermata Therapeutics, Inc. | 77% |
For institutional investors. Book with your work email.
Theravie Pharma, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 29, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 29, 2026
$750K raised in Seed round.
For institutional investors. Book with your work email.
Theravie Pharma, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Theravie Pharma, Inc.'s valuation, stock price, and market status.
Is Theravie Pharma, Inc. a public or private company?
Theravie Pharma, Inc. is a private company.
What is the current stock price of Theravie Pharma, Inc.?
Theravie Pharma, Inc. is a private company, so its shares have no public market price. Caplight tracks Theravie Pharma, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Theravie Pharma, Inc. worth (valuation)?
Valuation information for Theravie Pharma, Inc. is not publicly available.
Can I buy Theravie Pharma, Inc. stock?
Theravie Pharma, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Theravie Pharma, Inc.'s last funding round?
Theravie Pharma, Inc.'s most recent funding round was Seed on September 29, 2026.
Who are the main investors in Theravie Pharma, Inc.?
Investor information for Theravie Pharma, Inc. is not publicly disclosed.
Will Theravie Pharma, Inc. IPO soon?
No public IPO plans have been announced for Theravie Pharma, Inc..
How can I track Theravie Pharma, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Theravie Pharma, Inc.'s shares on secondary markets.